FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:345-347 February 3, 2000 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Ramakrishna, B.S. PubMed Citation

Oral rehydration therapy was developed in the 1960s. During the past three decades it has been used widely and successfully in the treatment of cholera and other diarrheal diseases. The use of oral rehydration therapy prevents the deaths of 1 million to 2 million children each year.¹ Cholera is an old, killer disease with the potential to create great pandemics. The disease is endemic in Asia, and there have been recent epidemics in Africa and Latin America and sporadic cases in the United States. These epidemics, together with the isolation and spread of a new type of vibrio cholera, O139 . . . [Full Text of this Article]

References

This article has been cited by other articles:

• (2000). Novel Oral Rehydration Therapy for Cholera. JWatch Infect. Diseases 2000: 5-5 [Full Text]